Join our Newsletter
Browse by Category
-
Most Read This Week
- Vical Incorporated announces results of herpes vaccine trial
- NIH studying newly emerging Staphylococcus aureus strain
- University of Cincinnati researchers develop oral breast cancer vaccine
- CDC issues update on fungal meningitis outbreak
- New findings could improve future whooping cough vaccine
- Swine-origin flu variant cases continue in U.S.
- Scientist map critical portion of anti-influenza antibody
- Boy dies from superbug infection at NIH hospital
- Progress made on new TB drug
Tags
Africa AIDS anthrax Avian flu Canada Cancer CDC Centers for Disease Control chicken pox China cholera Dengue fever Detection technology Ebola H1N1 H5N1 Hepatitis Hepatitis B HIV HPV Human papillomavirus immunization India Infectious disease Influenza Malaria Maryland Measles Medical Countermeasures meningitis MRSA Mumps News Pertussis pneumonia polio Preparedness research rotavirus Tuberculosis vaccine development West Nile virus whooping cough World Health Organization Yellow Fever
Tag Archives: HIV
NIAID: More research required in HIV Vaccine trial
Tweet Officials from the National Institute of Allergy and Infectious Diseases reported Monday the results from the follow-up HIV Vaccine Trials Network 503 Phambili, ultimately concluding that more research is necessary. The HVTN 503 trial began February 2007 to assess … Read More »
Canada vows continued support to fight disease
TweetJulian Fantino, Canada’s Minister of International Cooperation, announced on Monday Canada’s continuing support to fight tuberculosis, HIV and malaria. Fantino met with Mark Dybul, the new executive director for the Global Fund to Fight AIDS, Tuberculosis and Malaria, on Monday … Read More »
NIH scientists develop tool to identify HIV antibodies
TweetA team of scientists with the U.S. National Institutes of Health recently developed a new tool to identify powerful HIV antibodies that could prevent infection by the majority of HIV strains found worldwide. The NIH announced on Thursday the creation … Read More »
Burundi commits to halting new HIV infections among children
TweetA high-ranking government official in Burundi said on Wednesday the government is committed to stopping new HIV infections from occurring among children, according to the United Nations. Burundi’s Second Vice-President Gervais Rufykiri made the statement during a recent event marking … Read More »
Study shows good results for anti HIV, tuberculosis homeopathic
Tweet A study underway in the Ukraine reported on Wednesday that a complex homeopathic called Enercel is showing good results when used on patients with HIV and tuberculosis. Tuberculosis is one of the world’s leading causes of death. In 2010, … Read More »
HIV vaccine trial shines light on potential virus vulnerabilities
Tweet A HIV vaccine trial in Thailand recently gave Duke Human Vaccine Institute researchers insight to virus vulnerability via a new antibody response discovery. The Duke study, which appeared in Monday’s issue of Proceedings of the National Academy of Sciences, … Read More »
Lesotho cooperates with Global Fund to expand TB and HIV programs
TweetThe Global Fund to Fight AIDS, Tuberculosis and Malaria recently announced the signing of two grant agreements worth $17 million on Wednesday with Lesotho to expand the country’s treatment of HIV and multi-drug-resistant TB. Lesotho has the third highest HIV … Read More »
Malaria, TB and HIV vaccine research collaboration receives $2.9 million grant
TweetAeras, the University of Oxford and Okairos announced on Tuesday that they have received a $2.9 million grant to support their collaboration in the development of vaccines treating TB, HIV and malaria. The Bill & Melinda Gates Foundation, a private … Read More »